Despite hematologic malignancies such as leukemias and myeloproliferative disorders being highly prevalent in Africa, pathology laboratories in public cancer hospitals have limited capacity to diagnose patients. In response to requests from AAI partner hospitals, BVGH developed a 7-session French-language and a 9-session English-language set of digital courses titled “2024 AAI Pathology of Hematologic Malignancies”. The training series covered pathology concepts such as diagnostic techniques and fine needle aspiration for various hematologic malignancies, including leukemia, lymphoproliferative disorders, and myeloproliferative disorders. BVGH’s French-language program trained a total of 892 healthcare professionals from 36 different countries and the English-language course attracted over 1,300 participants from 70 countries. Lectures were given by experts from the University of North Carolina, Queen Mary University of London, PhenoPath Laboratories, University Hospital of Tubingen, Loyala University Medical Center, Hôpital Maisonneuve-Rosemont, CHU de Montréal, Hôpital Pitié-Salpêtrière, and the National Cancer Institute.
“Many thanks to the organizers, the teachers, and the whole team for the time, the knowledge, and the know-how that you have transmitted to us. Rest assured it will save the lives of some and improve that of others.”
– Dr. Israël Amen BABELA, General Practitioner at Bacongo Reference Hospital in Brazzaville, Congo
“This is one of the most comprehensive workshops on hematological malignancies I have attended. It was so insightful and rich in information. The materials from this workshop will be a foundational resource to which I will always reference going forward with regards to hematological malignancies.”
– English course participant